Your selections:
IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis
- Malhotra, S., Morcillo-Suárez, C., Chan, A., Vandenbroeck, K., Navarro, A., Bustamante, M. F., Rio, J., Akkad, D. A., Giacalone, G., Sánchez, A. J., Leyva, L., Alvarez-Lafuente, R., Brassat, D., Zettl, U. K., Oksenberg, J., Montalban, X., Comabella, M., Goertsches, R., Lechner-Scott, J., Urcelay, E., Fernández, O., Drulovic, J., García-Merino, A., Boneschi, F. Martinelli
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer
- Green, M. D., Francis, P. A., Gebski, V., Harvey, V., Karapetis, C., Chan, A., Snyder, R., Fong, A., Basser, R., Forbes, J. F., Australian New Zealand Breast Cancer Trials Group
Increasing central adiposity: the Nepean longitudinal study of young people aged 7-8 to 12-13 y
- Garnett, S. P., Cowell, C. T., Baur, L. A., Shrewsbury, V. A., Chan, A., Crawford, D., Salmon, J., Campbell, K., Boulton, Thomas J.
Are you sure you would like to clear your session, including search history and login status?